Janus Henderson Group PLC Argenx Se Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Argenx Se stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,565,399 shares of ARGX stock, worth $1.64 Billion. This represents 0.73% of its overall portfolio holdings.
Number of Shares
2,565,399
Previous 2,143,083
19.71%
Holding current value
$1.64 Billion
Previous $1.27 Billion
11.48%
% of portfolio
0.73%
Previous 0.73%
Shares
31 transactions
Others Institutions Holding ARGX
# of Institutions
490Shares Held
28.3MCall Options Held
370KPut Options Held
211K-
Price T Rowe Associates Inc Baltimore, MD4.98MShares$3.18 Billion0.31% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.78 Billion2.84% of portfolio
-
Capital World Investors Los Angeles, CA1.95MShares$1.24 Billion0.16% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.18MShares$749 Million11.81% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$645 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.3B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...